Search
Sunday 20 September 2015
  • :
  • :
Latest Update

News Buzz on: Yahoo! Inc. (NASDAQ:YHOO), GoPro Inc (NASDAQ:GPRO), Fifth Third Bancorp (NASDAQ:FITB), Evoke Pharma Inc (NASDAQ:EVOK)

On Tuesday, Yahoo! Inc. (NASDAQ:YHOO)’s shares inclined 2.37% to $31.04.

Yahoo! Inc.’s plans to spin off its stake in Alibaba Group Holding Ltd. without incurring a multibillion-dollar tax bill were left in doubt after U.S. officials outlined new concerns over transactions that mostly are intended to cut tax obligations.

The Internal Revenue Service said Monday that it has misgivings about deals like the one Yahoo is contemplating. The new notice shows that the IRS is stepping up scrutiny of transactions in which the business being spun off contains mainly investment assets or when the active business is small. Shares of the Web company rose 2.4 percent to $31.04 at the close in New York on Tuesday, leaving them down 39 percent this year.

Yahoo! Inc. provides search and display advertising services on Yahoo properties and associate sites worldwide. The company offers Yahoo Search that serves as a starting point to navigate the Internet and discover information; and Yahoo Answers, which enables users to seek, discover, and share knowledge and opinions across mobile phones, tablets, and desktops.

GoPro Inc (NASDAQ:GPRO)’s shares gained 2.10% to $33.57.

GoPro, Inc. (GPRO), enabler of some of today’s most engaging content, recently declared the limited availability of Odyssey, a new 16-camera rig designed for Google’s 3D, 360-degree virtual reality platform, Jump, through the Odyssey Limited Access Program (LAP). Starting recently, professional content creators and producers can apply to take part and purchase an Odyssey rig for delivery later this year.

First declared at Google’s annual developer conference, Google I/O, Odyssey offers a 360-degree camera array for stereoscopic 3D content capture. Features such as genlock camera synchronization, multi-camera control and extended battery life aim to eliminate challenges faced by content creators at the forefront of immersive content capture. Together, GoPro’s Odyssey and Google’s Jump platform will make it possible for anyone to experience a time or place like they’re actually there – through immersive, 3D, 360-degree content.

GoPro, Inc. develops hardware and software solutions to alleviate consumer pain points associated with capturing, managing, sharing, and enjoying engaging content. The company offers HERO line of capture devices, such as cameras; premium accessories, counting battery BacPac, smart remote, and LCD touch BacPac accessories; and mounts comprising equipment-based mounts comprising of helmet, handlebar, roll bar, and grip and tripod mounts that enable consumers to capture content while engaged in a range of activities, in addition to mounts that enable customers to wear the mount on their bodies, such as wrist housings, chest harnesses, and head straps.

At the end of Tuesday ‘s trade, Fifth Third Bancorp (NASDAQ:FITB)‘s shares surged 1.01% to $20.04.

Fifth Third Bancorp declared cash dividends on its common shares, Series J preferred shares, and Series I preferred shares.

Fifth Third Bancorp ( FITB) declared a cash dividend on its common shares of $0.13 for the third quarter of 2015. The dividend is payable on October 20, 2015 to shareholders of record as of September 30, 2015.

Fifth Third also declared a cash dividend on its 4.90% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series J, at the rate of $612.50 per preferred share, which equates to about $24.50 for each depositary share. Each depositary share represents a 1/25th ownership interest in a share of Series J Preferred Stock. The Series J dividend is payable on September 30, 2015 to shareholders of record as of September 25, 2015.

Fifth Third Bancorp operates as a diversified financial services company in the United States. It operates through four segments: Commercial Banking, Branch Banking, Consumer Lending, and Investment Advisors. The Commercial Banking segment offers credit intermediation, cash administration, and financial services; lending and depository products; and foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. The Branch Banking segment provides a range of deposit, loan, and lease products to individuals and small businesses.

Evoke Pharma Inc (NASDAQ:EVOK), ended its Tuesday ‘s trading session with 8.96% gain, and closed at $3.65.

Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, recently declared that its Phase 3 clinical trial design for EVK-001 (metoclopramide nasal spray) is consistent with the FDA’s recommendations in the recently released draft guidance entitled Gastroparesis: Clinical Evaluation of Drugs for Treatment — Guidance for Industry (Draft Guidance). The new Draft Guidance contains the FDA’s current thinking on trial design and study endpoints for drug development in the treatment of gastroparesis.

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It develops EVK-001, a metoclopramide nasal spray, which is in Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *